http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103536707-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98a6f82a0977d1bf23c8d8c72c5e74f5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-86 |
| filingDate | 2013-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab39d2fa841b7170902ff8e7615ccb47 |
| publicationDate | 2014-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103536707-A |
| titleOfInvention | Traditional Chinese medicinal prescription for treating acute conjunctivitis and preparation method thereof |
| abstract | The invention relates to a traditional Chinese medicinal prescription for treating acute conjunctivitis and a preparation method thereof, and belongs to the technical field of medicines. The invention provides a traditional Chinese medicinal prescription for treating acute conjunctivitis. The prescription consists of the following raw materials in parts by weight: 10-15 parts of senecio scandens, 10-15 parts of common scouring rush herb, 5-10 parts of cassia seed, 6-10 parts of fructus viticis, 5-10 parts of chrysanthemum, 8-14 parts of mulberry leaf, 8-15 parts of self heal, 3-5 parts of golden thread, 5-9 parts of dandelion, 5-10 parts of Chinese violet, and 5-9 parts of folium isatidis. The traditional Chinese medicinal prescription for treating acute conjunctivitis is prepared by scientific compatibility according to pathogenesis, has the functions of clearing heat and removing toxicity, diminishing inflammation and removing internal fire, cooling and activating blood and the like, and is quick in response, short in course of treatment and high in cure rate, so that the patient immunity can be improved, patients can be quickly recovered to normal work and life, the spreading rate is reduced, and the body health of surrounding people can be guaranteed. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104888014-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104888016-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104027621-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103989876-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940372-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940589-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107684565-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105168800-A |
| priorityDate | 2013-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 |
Total number of triples: 24.